Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY01005 vs Zoladex in Breast Cancer
NCT05110170Phase 3Completed
- Sponsor
- Luye Pharma Group
- Start
- Oct 2020
- Primary completion
- Apr 2022
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Baituowei in breast cancer, sponsored by Luye Pharma Group. Started Oct 2020; status: completed.
02
Drugs
Baituowei
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05110170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05110170.